Recently Viewed

News Announcement

Aurobindo Pharma: Compliance Certificate Under Regulation 40(9) For The Half Year Ended 30.09.2020

08-Oct-2020 Follow Value Research Online on Google download pdfDownload PDF Aurobindo Pharma

Pursuant to Regulation 40(9) and (10) of SESI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose the Compliance Certificate for the half year ended 30.09.2020.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.